CHARLENE BROWN: Open Payments
NPI 1760649008 · MUSCLE SHOALS, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$817 in 52 payments from 15 companies in 2025. Trend: 2023 $866 · 2024 $828 · 2025 $817
Food & beverage: $817
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $195 |
| AstraZeneca Pharmaceuticals LP | 9 | $149 |
| PFIZER INC. | 10 | $136 |
| Phathom Pharmaceuticals, Inc. | 6 | $95 |
| Vanda Pharmaceuticals Inc. | 2 | $48 |
| ABBVIE INC. | 2 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $29 |
| Ardelyx, Inc. | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| Boston Scientific Corporation | 1 | $17 |
Products named: Ozempic, VOQUEZNA, NURTEC ODT, BREZTRI, FANAPT, Wegovy, PREVNAR 20, AIRSUPRA.
Industry payments across AL — which companies pay providers there.
